重型创伤性脑损伤患者的神经立体学病灶体积与扩散性去极化:一项先导研究
这项多中心先导研究纳入50例重型创伤性脑损伤(TBI)术后患者,用连续皮层脑电图(ECoG)监测扩散性去极化(SD),中位监测79小时;用无偏立体学方法评估术前、术后和ECoG后系列CT的血肿和脑实质损伤体积;6个月时用扩展格拉斯哥结局量表评估神经功能结局。结果显示,术前硬膜下和蛛网膜下腔出血体积与SD发生显著相关(P值均<0.05),而脑实质损伤体积与SD发生无关;脑实质损伤从术前到ECoG后CT中位增加34 ml(四分位距-2,74),历时7(5,8)天;有SD与无SD患者的脑实质损伤增加程度无显著差异[47 ml(3,101)vs. 30 ml(-2,50),P=0.27],但出现等电型SD的患者初始脑实质损伤更大、增加也更多(P值均<0.05)。有SD时间簇(2小时内≥3次;n=10例)的患者结局比无簇者差(P=0.03),脑实质损伤扩大也与更差结局相关(P=0.01);在多变量回归(含插补)中,SD簇和病灶扩大均为显著的结局预测因子。作者认为,蛛网膜下腔和硬膜下出血是诱发SD的重要原发损伤因素,成簇SD和脑实质病灶扩大独立导致更差结局,需未来前瞻性研究对TBI病灶类型进行详细量化。
要点
- 重型TBI术后50例患者连续ECoG监测SD(中位79小时),术前硬膜下和蛛网膜下腔出血体积与SD发生显著相关(P值均<0.05),脑实质损伤体积与SD发生无关。
- 脑实质损伤从术前到ECoG后CT中位增加34 ml(四分位距-2,74),历时7(5,8)天;有SD与无SD患者的增加程度无显著差异[47 ml(3,101)vs. 30 ml(-2,50),P=0.27]。
- 出现等电型SD的患者初始脑实质损伤更大、增加也更多(P值均<0.05)。
- 有SD时间簇(2小时内≥3次;n=10例)的患者6个月结局比无簇者差(P=0.03),脑实质损伤扩大也与更差结局相关(P=0.01)。
- 多变量回归(含插补)中,SD簇和病灶扩大均为显著的结局预测因子。
适用人群与场景
- 多中心研究纳入50例重型创伤性脑损伤(TBI)接受手术治疗的患者,76%为男性,中位年龄40岁。
- 术后连续ECoG监测SD,中位监测时长79小时。
诊断标准与关键阈值
- SD时间簇定义为2小时内≥3次SD(n=10例患者)。
- 神经功能结局在6个月时用扩展格拉斯哥结局量表(Glasgow Outcome Scale-Extended)评估。
研究设计与关键结果
- 多中心先导研究,50例重型TBI术后患者,连续ECoG监测SD(中位79小时),用无偏立体学评估术前、术后和ECoG后系列CT的血肿和脑实质损伤体积,6个月用扩展格拉斯哥结局量表评估结局。
- 术前硬膜下和蛛网膜下腔出血体积与SD发生显著相关(P值均<0.05),脑实质损伤体积与SD发生无关。
- 脑实质损伤从术前到ECoG后CT中位增加34 ml(四分位距-2,74),历时7(5,8)天。
- 有SD与无SD患者的脑实质损伤增加程度无显著差异[47 ml(3,101)vs. 30 ml(-2,50),P=0.27]。
- 出现等电型SD的患者初始脑实质损伤更大、增加也更多(P值均<0.05)。
- 有SD时间簇(2小时内≥3次;n=10例)的患者结局比无簇者差(P=0.03),脑实质损伤扩大也与更差结局相关(P=0.01)。
- 多变量回归(含插补)中,SD簇和病灶扩大均为显著的结局预测因子。
证据类型、等级与局限
- 证据类型:多中心先导研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,蛛网膜下腔和硬膜下出血是诱发SD的重要原发损伤因素,成簇SD和脑实质病灶扩大独立导致更差结局。
- 作者认为,这些结果需未来前瞻性研究对TBI病灶类型进行详细量化,以更好理解继发性损伤的解剖与生理指标之间的关系。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Spreading depolarizations (SDs) occur in 50-60% of patients after surgical treatment of severe traumatic brain injury (TBI) and are independently associated with unfavorable outcomes. Here we performed a pilot study to examine the relationship between SDs and various types of intracranial lesions, progression of parenchymal damage, and outcomes.
METHODS: In a multicenter study, fifty patients (76% male; median age 40) were monitored for SD by continuous electrocorticography (ECoG; median duration 79 h) following surgical treatment of severe TBI. Volumes of hemorrhage and parenchymal damage were estimated using unbiased stereologic assessment of preoperative, postoperative, and post-ECoG serial computed tomography (CT) studies. Neurologic outcomes were assessed at 6 months by the Glasgow Outcome Scale-Extended.
RESULTS: Preoperative volumes of subdural and subarachnoid hemorrhage, but not parenchymal damage, were significantly associated with the occurrence of SDs (P's < 0.05). Parenchymal damage increased significantly (median 34 ml [Interquartile range (IQR) - 2, 74]) over 7 (5, 8) days from preoperative to post-ECoG CT studies. Patients with and without SDs did not differ in extent of parenchymal damage increase [47 ml (3, 101) vs. 30 ml (- 2, 50), P = 0.27], but those exhibiting the isoelectric subtype of SDs had greater initial parenchymal damage and greater increases than other patients (P's < 0.05). Patients with temporal clusters of SDs (≥ 3 in 2 h; n = 10 patients), which included those with isoelectric SDs, had worse outcomes than those without clusters (P = 0.03), and parenchymal damage expansion also correlated with worse outcomes (P = 0.01). In multivariate regression with imputation, both clusters and lesion expansion were significant outcome predictors.
CONCLUSIONS: These results suggest that subarachnoid and subdural blood are important primary injury factors in provoking SDs and that clustered SDs and parenchymal lesion expansion contribute independently to worse patient outcomes. These results warrant future prospective studies using detailed quantification of TBI lesion types to better understand the relationship between anatomic and physiologic measures of secondary injury.
参考来源
- Eriksen N, Pakkenberg B, Rostrup E, et al. Neurostereologic Lesion Volumes and Spreading Depolarizations in Severe Traumatic Brain Injury Patients: A Pilot Study. Neurocrit Care. 2019. PMID: 30972614. doi:10.1007/s12028-019-00692-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。